skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Global cancer research initiative

Expert Opinion

(3118) Views  (889) Full article downloads

Authors: Richard R Love

Published Date May 2010 Volume 2010:2 Pages 105 - 109
DOI: http://dx.doi.org/10.2147/CMAR.S9514

Richard R Love

The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA

Abstract: Cancer is an increasing problem for low- and middle-income countries undergoing an epidemiologic transition from dominantly acute communicable disease to more frequent chronic disease with increased public health successes in the former domain. Progress against cancer in high-income countries has been modest and has come at enormous expense. There are several well-conceived global policy and planning initiatives which, with adequate political will, can favorably impact the growing global cancer challenges. Most financial resources for cancer, however, are spent on diagnosis and management of patients with disease in circumstances where specific knowledge about effective approaches is significantly limited, and the majority of interventions, other than surgery, are not cost-effective in resource-limited countries by global standards. In summary, how to intervene effectively on a global scale for the majority of citizens who develop cancer is poorly defined. In contrast to technology-transfer approaches, markedly increased clinical research activities are more likely to benefit cancer sufferers. In these contexts, a global cancer research initiative is proposed, and mechanisms for realizing such an effort are suggested.

Keywords: breast cancer, research, global, international, low-income, middle-income








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
EGFR may couple moderate alcohol consumption to increased breast cancer risk
Optimal management of cancer anorexia–cachexia syndrome
Role of bevacizumab therapy in the management of glioblastoma
Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit
Progress in the development of a therapeutic vaccine for breast cancer
Cancer prevention, aerobic capacity, and physical functioning in survivors related to physical activity: a recent review
Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
Phenotype characterization of embryoid body structures generated by a crystal comet effect tail in an intercellular cancer collision scenario
A triple negative breast cancer: what it is not!
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University